Categories: Wire Stories

Mannatech Declares Third Quarter 2022 Dividend

FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20per share of common stock, payable on Wednesday, December 28, 2022, to shareholders of record at the close of business on Wednesday, December 14, 2022. The dividend demonstrates a commitment to rewarding shareholders and encouraging long-term investment in Mannatech�s common stock.

Alfredo “Al” Bala, President and CEO of Mannatech, said, “Mannatech is fully committed to delivering value to our shareholders.”

About Mannatech

Mannatech, Incorporated is committed to transforming lives through the development of high quality integrated health, weight management, fitness and skin care products distributed through its global network of independent associates and members. The company has been operating for more than 25 years with operations in 25 markets^. For more information, visit Mannatech.com.

^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.

Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” “hope,” “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the outbreak of the novel coronavirus (“COVID-19”) pandemic, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contacts

Donna Giordano

Manager, Executive Office Administration

972-471-6512

ir@mannatech.com
www.mannatech.com

Alex

Recent Posts

Capstone Copper Announces 2024 Annual General and Special Meeting Results

VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…

9 hours ago

Indonesia International Remittance Market Growth and Future Opportunities 2024-2028: Rising Transaction Values and Volumes Characterize the Landscape – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…

9 hours ago

KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance

KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…

15 hours ago

Firstsource Acquires Quintessence

Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…

16 hours ago

UPCX Becomes the Main Sponsor for Coinfest Asia 2024

SINGAPORE - Media OutReach Newswire - 3 May 2024 - UPCX (UPC), a developer of…

16 hours ago

China Biological Reagents (Molecular Biology Reagents, Proteins and Cell Reagents) Industry Research 2023-2024 & 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights &…

17 hours ago